ATHOS THERAPEUTICS
Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
ATHOS THERAPEUTICS
Industry:
Artificial Intelligence (AI) Biotechnology Life Science Medical
Founded:
2019-01-01
Status:
Active
Contact:
310-866-5610
Total Funding:
54.25 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin Cloudflare JS
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Novasenta
Novasenta develops treatments to transform the lives of patients with cancer.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
InterVenn
InterVenn Biosciences identifies, quantifies, and classifies Glycoproteomic and other PTM signals found in human blood and tissue.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Employees Featured
Allan J. Pantuck Co-Founder, and Chief Medical Officer @ Athos Therapeutics
Co-Founder, and Chief Medical Officer
Dimitrios Iliopoulos CEO, President @ Athos Therapeutics
CEO, President
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-05-24 | RedDress | Athos Therapeutics investment in Series D - RedDress | 26 M USD |
More informations about "Athos Therapeutics"
Our Team - Athos Therapeutics
The Athos Therapeutics Scientific Advisory Board (SAB) is comprised of an unrivaled, international group of world-renowned leaders who are experts in the fields of immunology, inflammatory bowel diseases, drug discovery and …See details»
Athos, an autoimmune and cancer biotech, is raising …
Feb 16, 2024 Athos Therapeutics is raising a $35 million Series B, ... (“BioscienceLA”) is an independent 501(c)(3) not-for-profit organization formed by Los Angeles County in 2018 with backing from Amgen, PhRMA, Richard …See details»
Athos Therapeutics - Crunchbase Investor Profile
Legal Name Athos Therapeutics, Inc. Company Type For Profit; Phone Number 310-866-5610; Athos Therapeutics is a late pre-clinical stage biotechnology …See details»
Athos Announces Positive Topline Phase 1 Data for its …
LOS ANGELES, October 16, 2024 — Athos Therapeutics, Inc. (“Athos”), a clinical stage biotechnology company pioneering the development of precision small molecule therapeutics for patients with immune-mediated diseases, today …See details»
Athos Therapeutics, Inc. - Drug pipelines, Patents, …
Explore Athos Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 12 news, and 6 literature, Disease Domain:Immune System Diseases, Neoplasms, Hemic and Lymphatic …See details»
Athos Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 16, 2024: Series B - Athos …See details»
Athos Therapeutics - PitchBook
Athos Therapeutics was founded in 2019. Where is Athos Therapeutics headquartered? Athos Therapeutics is headquartered in Los Angeles, CA. What industry is Athos Therapeutics in? Athos Therapeutics’s primary industry is …See details»
Athos Therapeutics - VentureRadar
Athos Therapeutics develops first-in-class medications that will significantly impact the lives of patients with autoimmune disorders, chronic inflammatory diseases, and cancer. Athos has …See details»
Athos Therapeutics Announces the Autonomization of …
Mar 5, 2024 Athos Therapeutics . Tue, Mar 5, 2024, 11:00 AM 3 min read. The Athos Computational Platforms are now Disease Agnostic with an AI/ML framework powered by Autonomous Transcriptomics and Proteomics ...See details»
All Three Athos Co-Founders Named to Stanford’s List of the …
Oct 12, 2023 LOS ANGELES, CA / ACCESSWIRE / October 12, 2023 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of artificial …See details»
Athos Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Athos Therapeutics, Inc. of Torrance, CA. Get the latest business insights from Dun & Bradstreet.See details»
Athos, an autoimmune and cancer biotech, is raising $35M for …
Feb 16, 2024 Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will deploy the money on its AI-based precision small …See details»
Dimitrios Iliopoulos, PhD MBA - Athos Therapeutics
Dr. Dimitrios Iliopoulos is the President, CEO and a co-Founder of Athos Therapeutics Inc. He started his academic career at Harvard Medical School where he was an Assistant Professor …See details»
Athos, an autoimmune and cancer biotech, is raising $35M for …
Feb 16, 2024 Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will deploy the money on its AI-based precision small …See details»
Dimitrios Iliopoulos - The Montgomery Summit
Dr. Dimitrios Iliopoulos is the President, CEO and a co-Founder of Athos Therapeutics Inc. He started his academic career as an Assistant Professor at Harvard Medical School, and more …See details»
Athos Therapeutics - VentureRadar
Ichnos Therapeutics USA Privately Held Ichnos Sciences, a biotech spin-off from Glenmark, is shifting the way the world thinks about innovation in medicine through its research and …See details»
Athos Therapeutics Receives Regulatory Approval to
Apr 4, 2023 Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of artificial intelligence-based precision small molecule …See details»
Athos Announces Positive Topline Phase 1 Data for its AI …
Oct 16, 2024 Athos Therapeutics . Wed, Oct 16, 2024, 9:00 AM 4 min read. ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and …See details»
AHF Calls Out Prime Therapeutics’ Lies After $10M PBM Price …
Jan 28, 2025 AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, a nonprofit, and the winner of the King Center's MLK Jr. Social Justice Award, …See details»
Athos Therapeutics Receives Regulatory Approval to Commence …
Mar 29, 2023 The Mission of Athos Therapeutics is to develop first-in-class medications that will significantly impact the lives of patients with autoimmune disorders, chronic inflammatory …See details»